Clin2
NCT07055893Possibly a fitNot yet recruiting

Rabies vaccine for preventing infection after exposure

Rabies (Healthy Volunteers)

Treatments studied

Part of Infections clinical trials.

This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
390 people
Ages
1 year and older
Study type
Interventional

Who can take part

  • Be at least 1 year old.
  • Have no prior rabies vaccination (any kind).
  • Have not been bitten or exposed to a potentially rabid animal in the last 12 months.
  • Be in generally stable health – no major uncontrolled chronic conditions.
  • If female and of childbearing age, not be pregnant or breastfeeding and agree to use effective contraception during the study.
  • Be able to attend study visits and receive injections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07416110Not yet recruiting· Phase 3
Testing different batches of the rabies vaccine in healthy adults

This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.

Deyang
NCT07445815Not yet recruiting· Phase 2
Testing a lab-made antibody for rabies prevention in healthy adults

This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.

Lanzhou, Gansu
NCT07455318Not yet recruiting· Phase 3
Rabies vaccine booster after pre-exposure doses

This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.

Antwerp
NCT07055295Not yet recruiting· Phase 3
Rabies vaccine for prevention before exposure

This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.

Rawalpindi
NCT07055880Not yet recruiting· Phase 2
Rabies vaccine doses for adults 18 to 59

This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.

Karachi
NCT07168018Not yet recruiting· Phase 2
Testing a new rabies vaccine with the standard one

This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.

Bagamoyo

Hear when a new Rabies (Healthy Volunteers) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.